Pfizer to pay over $2B for developer of cancer treatments
Pfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments.
More from Arkansas Business
Arkansas Democratic Gazette | Business
Northwest Arkansas Business Briefs
Arkansas Business
•
3h ago
Arkansas Democratic Gazette | Business
Stone Bank hires Ashley East as vice president and relationship development officer
Arkansas Business
•
4h ago
Arkansas Democratic Gazette | Business
$60 million Riggs facility to generate 75 jobs, open in 2027
Arkansas Business
•
1d ago
Talk Business Arkansas
Inflation expected to push holiday sales above $1 trillion
Arkansas Business
•
1d ago
Talk Business Arkansas
Rogers to vote on $457 million bond for street, park projects
Arkansas Business
•
1d ago
Arkansas Democratic Gazette | Business
Arkansas Agriculture Hall of Fame accepting nominations
Arkansas Business
•
2d ago
Arkansas Democratic Gazette | Business
J.B. Hunt Transport Services Inc. reports $172.4 million quarterly profit
Arkansas Business
•
2d ago
Arkansas Democratic Gazette | Business
Rogers-based America's Car-Mart gets seventh extension on loan terms from original Sept. 7 deadline
Arkansas Business
•
2d ago